Predictive Parameters for Therapeutic Efficacy of Initial Combination Therapy With Sitagliptin and Metformin in Type 2 Diabetic Patients.

Trial Profile

Predictive Parameters for Therapeutic Efficacy of Initial Combination Therapy With Sitagliptin and Metformin in Type 2 Diabetic Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jan 2012

At a glance

  • Drugs Metformin (Primary) ; Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms COSMETIC
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jun 2011 Planned end date changed from May 2011 to Jul 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top